Navigation Links
Houston's Methodist Hospital to Pay U.S. More Than $9 Million to Resolve Allegations of Overcharging Medicare
Date:3/26/2009

WASHINGTON, March 26 /PRNewswire-USNewswire/ -- Methodist Hospital in Houston has agreed to pay the United States $9.99 million to settle allegations that it defrauded the federal Medicare program, the Justice Department announced today.

The settlement resolves allegations that Methodist improperly increased charges to Medicare patients in order to obtain enhanced reimbursement from Medicare. In addition to its standard payment system, Medicare pays supplemental reimbursement, called outlier payments, to hospitals in cases where the cost of care is unusually high. Congress enacted the supplemental outlier payment system to ensure that hospitals possess the incentive to treat inpatients whose care requires unusually high costs.

The government alleged that, between January 2001 and August 2003, Methodist improperly inflated charges for inpatient and outpatient care to make its costs for providing such care appear greater than they actually were, and thereby obtain outlier payments from Medicare that it was not entitled to receive.

"Today's settlement demonstrates the continued commitment by the Justice Department to protect Medicare when it is overcharged by hospitals," said Acting Assistant Attorney General for the Civil Division, Michael F. Hertz. "The Department has brought numerous actions against hospitals alleged to have sought excessive outlier payments, and will remain vigilant in ensuring that hospitals do not file false claims for outlier payments in the future."

"Our ultimate goal is to make certain that every Medicare dollar is used for the benefit of Medicare recipients," said Tim Johnson, acting U.S. Attorney, Southern District of Texas. "We will continue in our efforts to assure that is done."

The settlement with Methodist was the result of a coordinated effort among the Justice Department's Commercial Litigation Branch in the Civil Division; the U.S.
'/>"/>

SOURCE U.S. Department of Justice
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Methodist Health System Prostate Cancer Screening Program Wins Statewide Community Service Award
2. Methodist Weight Management Institute Brings NBCs Biggest Loser to Dallas and Mansfield
3. Photo: United Methodist Church, Partners Launch Life-Saving Campaign in Cote dIvoire
4. World-Renowned Physicians Converge on Methodist Dallas Medical Center for Largest Live Demonstration of Its Kind in Texas
5. Local Methodists Host West African Choir, South African Leader at Historic Conference
6. Methodist Healthcare - Memphis Hospitals Announces Termination of Tender Offers
7. Methodist Healthcare - Memphis Hospitals Announces the Extension of Tender Offers
8. Ben Barber Career Tech Academy Leaps Forward With Help From Methodist Mansfield
9. New Sleep Diagnostic Center Opens at Methodist Mansfield
10. Methodist Healthcare - Memphis Hospitals Announces the Commencement of the Tender Offer for Certain Designated Maturities of:
11. New York Methodist Hospital to study airway bypass treatment for emphysema
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... (PRWEB) July 25, 2014 AttorneyOne.com, a recognized ... latest information from the FDA on Ibuprofen and Oxcarbazepine ... that one lot of Ibuprofen and one lot of Oxcarbazepine ... due to mislabeled packaging. Oxcarbazepine is used for the treatment ... , The reason for the recall is that Lot ...
(Date:7/25/2014)... July 25, 2014 Parker Waichman LLP, ... of consumers comments on a recent tobacco lawsuit in ... smoker $23.6 billion in punitive damages. Cynthia Robinson brought ... cigarettes. The case is Cynthia Robinson v. R.J. Reynolds ... Florida First Circuit Court, Escambia County, Florida; Case Number ...
(Date:7/25/2014)... Drexel University College of Medicine is pleased ... been appointed vice dean for education, effective October 1, 2014. ... Medical College, where she is currently chair of the Department ... of medicine. , As a member of the senior ... major role in many aspects of the development of the ...
(Date:7/25/2014)... vulnerable neurons and reduce motor deficits in a ... University School of Medicine have shown. , The ... Parkinson,s Disease . , The findings demonstrate that ... at sufficient levels and have beneficial effects when ... Previous studies of XPro1595 in animals tested more ...
(Date:7/25/2014)... 25, 2014 The new report ... Feed, Pharmaceuticals and Others), by Type (Amylases, Cellulases, ... Geography - Global Trends & Forecasts to 2019", ... of the global Carbohydrase market with analysis of ... is segmented and values are forecasted on the ...
Breaking Medicine News(10 mins):Health News:Ibuprofen and Oxcarbazepine Tablets Recalled: AttorneyOne Monitors and Keep Consumers Informed 2Health News:A Florida Jury Awards Widow More Than $23 Billion in Punitive Damages in a Lawsuit Brought Against Tobacco Maker, R.J. Reynolds, Parker Waichman LLP Comments 2Health News:A Florida Jury Awards Widow More Than $23 Billion in Punitive Damages in a Lawsuit Brought Against Tobacco Maker, R.J. Reynolds, Parker Waichman LLP Comments 3Health News:Valerie D. Weber, MD, Appointed Vice Dean for Education at Drexel University College of Medicine 2Health News:Valerie D. Weber, MD, Appointed Vice Dean for Education at Drexel University College of Medicine 3Health News:Anti-inflammatory drug can prevent neuron loss in Parkinson's model 2Health News:Carbohydrase Market worth $3,717.7 Million by 2019 - Report by MarketsandMarkets 2Health News:Carbohydrase Market worth $3,717.7 Million by 2019 - Report by MarketsandMarkets 3Health News:Carbohydrase Market worth $3,717.7 Million by 2019 - Report by MarketsandMarkets 4
... Universal Capital Management, Inc. (OTC Bulletin Board: ... provides management and strategic growth resources to emerging ... of its holdings, iVolution Medical Systems, Inc., recently ... service company located in New York City, New ...
... Tamiflu in stock for consumers who do not yet have the ... required, patients must provide their health information and medical history before ... 1-800-467-0297. Patients should not take Tamiflu until flu symptoms are ... ...
... will add several new core and elective clinical rotations at Danbury Hospital ... ... 2009-- Ross University School of Medicine is pleased to announce it will ... of clinical rotations on the East Coast. The new placements will be ...
... and controversial policy change made by Blue Cross Blue Shield of Massachusetts ... venous community--from patients to physicians to the businesses that provide vein-related goods ... ... of mid April, 2009, BCBS has mandated that in the state of ...
... RIO DE JANEIRO, Brazil, May 12 Amilpar ... the largest managed care organization in Brazil, announced today its ... At the end of March, total membership ... 2.3% down on the 3.18 million recorded in the 4Q08.Adjusted ...
... The American College of Medical Genetics (ACMG) has ... American Pathologists, and the American Society for Clinical Pathology ... the human genes associated with breast and ovarian cancer ... options regarding their health care. The lawsuit challenges patents ...
Cached Medicine News:Health News:iVolution Medical Systems Acquires Continental Collection Services 2Health News:AccessRx.com Provides Same-Day Shipping for Tamiflu, an Effective Treatment for Swine Flu 2Health News:Ross University School of Medicine Expands Clinical Rotations on East Coast 2Health News:Blue Cross/Blue Shield Of Massachusetts Introduces Controversial Criteria For Vein Treatment Reimbursement 2Health News:Blue Cross/Blue Shield Of Massachusetts Introduces Controversial Criteria For Vein Treatment Reimbursement 3Health News:Amilpar - Revenue Increases 13.4% and Medical Loss Ratio Falls in the First Quarter 2009 2Health News:ACMG Joins Lawsuit Challenging Patents on Breast Cancer Genes; Genes Are Naturally Occurring Substances and Should Not Be Patented, Says American College of Medical Genetics 2Health News:ACMG Joins Lawsuit Challenging Patents on Breast Cancer Genes; Genes Are Naturally Occurring Substances and Should Not Be Patented, Says American College of Medical Genetics 3
(Date:7/24/2014)... 2014  Parnell Pharmaceuticals Holdings Ltd announces the ... added to Parnell,s already extensive pipeline through a ... biotechnology company. The compounds now known as PAR ... bone regeneration and dermal regeneration, respectively. Parnell has ... the veterinary market with the potential to also ...
(Date:7/24/2014)... MARSEILLE , Frankreich, July ... , Weltweite Exklusivlizenz der Universität ... Entwicklung von Tests auf SF3B1-Mutationen, einschließlich von ... Neuer Test weist Mutationen des SF3B1-Gens nach, ... einen günstigen Krankheitsverlauf vermuten lassen  ...
(Date:7/24/2014)... 2014  Abaxis, Inc. (NasdaqGS: ABAX ), ... today reported financial results for the first fiscal quarter ... , Revenues of $47.5 million, up 10% over ... $0.21, up 50% over last year,s comparable quarter. ... $7.2 million, up 20% over last year,s comparable quarter. ...
Breaking Medicine Technology:Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 2Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 3Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 4QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 2QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 3QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 4QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 2Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 3Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 4Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 6Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 7Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 8Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 9Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 10Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 11
... Minn., Oct. 7 Prime Therapeutics (Prime) announces that it ... of Care. Wickersham will manage Prime,s Clinical and ... medical and pharmacy. In this role, he will be responsible ... breakthrough results for Prime and its clients. "Keeping ...
... MINNEAPOLIS, Oct. 7 Nonin Medical, Inc., a ... today the release of its second-generation wrist-worn pulse ... PureSAT® SpO2 technology, the WristOx2, Model 3150 is ... proven accuracy in the widest range of clinical ...
Cached Medicine Technology:Prime Therapeutics Hires Peter Wickersham, Senior Vice President Cost of Care 2Nonin Medical Announces Its Second-Generation Wrist-Worn Device for European Distribution: Delivering Reliability in the Widest Range of Patient Populations and Clinical Settings 2
The Atria 6100 delivers the highest level of clinical performance while incorporating cutting-edge technology to streamline clinic workflow. It offers timely, high-quality, and accurate ECG results c...
... test face is used to evaluate both low ... (high, 25% and 12.5%) of LogMAR acuity (20/16 ... as well as the two spatial frequencies of ... widely used for cataract documentation because eye doctors ...
... The CSV-1000RS test face is used widely ... presents ETDRS LogMAR acuity from 20/10 to ... at 12 cycles/degree. , ,The patient can ... for ETDRS acuity and contrast sensitivity. If ...
... monza is the latest addition to the ... It is a compact, semi-automated clinical analyser ... RX monza is a complete clinical analyser ... Designed for straightforward operation and consistent performance, ...
Medicine Products: